New co-editors offer focus on endocrinology subspecialties
Click Here to Manage Email Alerts
In pursuit of our goal to provide broad coverage of issues and topics of concern to the endocrine community and to leave no subspecialty unfocused, five leaders in endocrinology have joined Healio | Endocrine Today as co-editors.
Advancements are occurring across endocrinology every day. Staying on top of the issues of interest to all our readers requires close collaboration with the experts. As a result, Healio | Endocrine Today has adopted a new leadership design with multiple co-editors from various subspecialty areas within endocrinology. The new co-editors will assist in content selection and review and act as ambassadors for the publication.
Joining Healio | Endocrine Today are Andrea E. Dunaif, MD; Maria Fleseriu, MD, FACE; James R. Gavin III, MD, PhD; Sangeeta R. Kashyap, MD; and Richard E. Pratley, MD.
Dunaif is the Lillian and Henry M. Stratton Professor of Molecular Medicine and chief of the Hilda and J. Lester Gabrilove division of endocrinology, diabetes and bone disease at the Icahn School of Medicine and the Mount Sinai Health System in New York. Her research into polycystic ovary syndrome has greatly influenced the understanding and treatment of the condition.
“What I enjoy about working with Healio | Endocrine Today is the ability to bring important literature to the attention of the general endocrinologist community and to concisely evaluate the impact of research on the field as well as on clinical care,” Dunaif said. “Healio | Endocrine Today is an invaluable resource for busy clinicians to keep them abreast of the latest advances in the field.”
Fleseriu is professor of medicine and neurological surgery and director of the Pituitary Center at Oregon Health & Science University in Portland. Her clinical and research work on pituitary disorders led to significant advances in new therapies and an individualized treatment for improving patient outcomes in Cushing’s disease and acromegaly.
“During the first year of medical school, I found a fascination [with] the superb regulatory mechanism between hypothalamus-pituitary-target glands. The fact that a pea-size gland is the ultimate master gland intrigued me, so my first research project that year focused on improving imaging of the pituitary. This was the moment in which neuroendocrinology became my passion,” Fleseriu said.
Sharing this passion is Fleseriu’s goal in joining Healio | Endocrine Today.
“I am looking forward to highlighting for our clinician readers all the exciting studies and developments in pituitary and adrenal disorders. Rare diseases may have been overlooked in the past, and now we are focusing more to increase awareness about diagnosis and also personalized treatment with the goal of improving each patient’s outcome,” she said.
Gavin is clinical professor of medicine at Emory University and chief medical officer of Healing Our Village, a corporation that specializes in targeted advocacy, training, education, disease management, and outreach for health care professionals and minority communities. He was the first African American president of the American Diabetes Association in 1993 and president of Morehouse School of Medicine in Atlanta a decade later. He is currently the board-elected director of the Association of Diabetes Care & Education Specialists.
Gavin sees his role as co-editor in disseminating key advancements in diabetes care to busy clinicians.
“For a complex, dynamic disease like type 2 diabetes, the growing capabilities of personalized medicine generated by the rich harvest of huge real-world databases, novel combination therapies, integrated remote monitoring and user-friendly self-management programs will promote more effective prevention, earlier detection and improved management of this disease,” Gavin said.
Kashyap is a physician scientist in the Endocrinology Institute at Cleveland Clinic and professor of medicine at the Cleveland Clinic Lerner College of Medicine. Her clinical and research focus is on insulin resistance, type 2 diabetes, and weight loss and endocrine effects of bariatric surgery.
“As an active clinical investigator in the field of diabetes and obesity, which is constantly evolving with new therapies and innovations, my role as co-editor is to provide the health care community with practical insights,” Kashyap said. “The field of diabetes and obesity has had a number of major developments, new therapies and innovations in clinical care. We’re finally making a dent into obesity management that is impacting care of a variety of adiposity-based chronic diseases that are so prevalent in our society.”
Pratley is the Samuel E. Crockett Chair in Diabetes Research, senior investigator and diabetes program lead at the AdventHealth Translational Research Institute, and medical director at the AdventHealth Diabetes Institute in Orlando. He is also an adjunct professor of medicine at the Johns Hopkins School of Medicine. His current research interests include developing new drugs to prevent and treat obesity and diabetes and the ensuing complications, improving care for older adults with diabetes, and understanding how adiposity increases diabetes and cardiovascular risks.
“The last decade has seen an explosion of high-quality, practice-changing research in obesity and diabetes, including the development of new classes of drugs that not only improve glycemia, but decrease risk for cardiovascular disease, heart failure and chronic kidney disease. Looking into the future, I expect that this trend will continue, if not accelerate,” Pratley said. “It is tough for even the most dedicated, well-read clinicians to keep on top of all the new developments. I am excited to be working with Healio | Endocrine Today because we have the opportunity to highlight important new research and get the perspectives of the leaders from these key studies.”
Expanded Editorial Board
With the October issue, Healio | Endocrine Today is also adding several new experts to its Editorial Board, diversifying voices across subspecialty, career stage, gender and background. Board members provide perspective on research and practice and help to develop cover stories, editorials and news of interest to the endocrine community.
Among the new voices are Jamy D. Ard, MD; Arti Bhan, MD, FACE; Ricardo Correa, MD, EsD, FACE, FACP, CMQ; Elizabeth H. Holt, MD, PhD; Silvio Inzucchi, MD; Elizabeth N. Pearce, MD, MSc; and Fatima Cody Stanford, MD, MPH, MPA.
In addition to our new co-editors and board members, we welcome your thoughts and ideas about important stories to cover. Thank you for reading.